BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28259790)

  • 1. Private Funding for Pancreatic Cancer Research: More Than a Chip Shot.
    Hendifar AE; Davies L; Tuli R
    Gastroenterology; 2017 Apr; 152(5):918-921.e2. PubMed ID: 28259790
    [No Abstract]   [Full Text] [Related]  

  • 2. Mapping the European cancer research landscape: An evidence base for national and Pan-European research and funding.
    Begum M; Lewison G; Lawler M; Sullivan R
    Eur J Cancer; 2018 Sep; 100():75-84. PubMed ID: 30014883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crowdfunding for cancer research: the TRACe campaign as an example.
    Gallerani G; Fici P; Coatti A; Mariotti P; Passeri F; Battistelli L
    Lancet Oncol; 2019 May; 20(5):622-624. PubMed ID: 31044702
    [No Abstract]   [Full Text] [Related]  

  • 4. Scientists worry as cancer moonshots multiply.
    Check Hayden E
    Nature; 2016 Apr; 532(7600):424-5. PubMed ID: 27121817
    [No Abstract]   [Full Text] [Related]  

  • 5. National expenditure on health research in South Africa: How has the landscape changed in the past decade?
    Barnabé MA; Gordon R; Ramjee G; Loots G; Blackburn JM
    S Afr Med J; 2020 Mar; 110(4):274-283. PubMed ID: 32657738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new era of hope for the world's most neglected diseases.
    The
    PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Fund financing of public-private mix approaches for delivery of tuberculosis care.
    Lal SS; Uplekar M; Katz I; Lonnroth K; Komatsu R; Yesudian Dias HM; Atun R
    Trop Med Int Health; 2011 Jun; 16(6):685-92. PubMed ID: 21332892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking through. Upbeat reports on medical research highlight value of federal, private funding.
    May D
    Mod Healthc; 2011 Aug; 41(35):25. PubMed ID: 21932707
    [No Abstract]   [Full Text] [Related]  

  • 9. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need.
    Moran M
    PLoS Med; 2005 Sep; 2(9):e302. PubMed ID: 16138789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer research funding in Europe low compared with U.S., survey finds.
    Illman J
    J Natl Cancer Inst; 2005 May; 97(10):713-4. PubMed ID: 15900040
    [No Abstract]   [Full Text] [Related]  

  • 11. Cultivating and investing in clinical research in China.
    Zhang J; Huang H; Shen X
    Lancet; 2015 Oct; 386(10002):1506-8. PubMed ID: 26466054
    [No Abstract]   [Full Text] [Related]  

  • 12. The NIH budget and the future of biomedical research.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006
    [No Abstract]   [Full Text] [Related]  

  • 13. [The public and the private healthcare sector in Spain: stability or change?].
    Rodríguez M
    Gac Sanit; 2019; 33(6):499-501. PubMed ID: 31585771
    [No Abstract]   [Full Text] [Related]  

  • 14. Public-private partnerships boost research on neglected diseases.
    Louët S
    Nat Biotechnol; 2003 Nov; 21(11):1254-5. PubMed ID: 14595339
    [No Abstract]   [Full Text] [Related]  

  • 15. Translating translational research.
    Laurence J
    Transl Res; 2006 Jul; 148(1):1-3. PubMed ID: 16887490
    [No Abstract]   [Full Text] [Related]  

  • 16. Data sharing: making headway in a competitive research milieu.
    Samson K
    Ann Neurol; 2008 Jul; 64(1):A13-6. PubMed ID: 18668610
    [No Abstract]   [Full Text] [Related]  

  • 17. Fundraising 101: why seek private funding?
    Duyck GP
    J Public Health Manag Pract; 2008; 14(2):199-201. PubMed ID: 18287928
    [No Abstract]   [Full Text] [Related]  

  • 18. Public spending for health care approaches 60 percent.
    Fox DM; Fronstin P
    Health Aff (Millwood); 2000; 19(2):271-4. PubMed ID: 10718043
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring the government/industry interface--the NIH SBIR STTR program.
    Etzler K
    J Dent Hyg; 2009; 83(4):210-1. PubMed ID: 19909652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.